Sarah Alrasheed: New Evidence on Transitioning From Parenteral Prostacyclin to Selexipag
Sarah Alrasheed, Associate Consultant in Pulmonary Medicine at King Faisal Specialist Hospital and Research Center, shared on LinkedIn:
“I am pleased to share that our latest research has been published in Pulmonary Circulation. In this study, we address a critical and sensitive clinical question: the transition from parenteral prostacyclin therapy to Selexipag.
Until now, many of us in clinical practice have had limited evidence to guide whether transitioning to oral prostacyclin pathway therapy is safe and feasible, and most importantly: what the safety implications of this decision are for our patients. Our findings aim to provide practical, real world guidance to support clinicians facing this complex decision.
I hope this work proves valuable for your practice and for the care of patients with pulmonary hypertension.
You can access the article here.”
Article: Transitioning From Parenteral Prostanoids to Oral Selexipag in Pulmonary Arterial Hypertension: A Multicenter Retrospective Cohort Study
Authors: Brandon Budhram, Sarah K. Alrasheed, Moaaz Rashad, George Chandy, Anna Dvorkin-Gheva, George A. Fox, Julia Foxall, Andrea Gardner, Doug Helmersen, Naushad Hirani, Kristina Kemp, Mithum Kularatne, David Langleben, Lyda Lesenko, Steeve Provencher, Emma Spence, John R. Swiston, Mitesh Thakrar, Daniel Wadden, Jason Weatherald, Nathan Hambly
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 19:35Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together
-
Jun 7, 2026, 18:24Yvette Fairfax: Wiskott-Aldrich Gene Therapy Changes Immunity, but Affordability May Determine Survival
-
Jun 7, 2026, 18:21Gulab Makwana: Complete Guide to Clotting Factors – Understanding the Coagulation System
-
Jun 7, 2026, 18:15Chuhan Dong: Presenting My Research on Antibody-Mediated RBC Clearance at Canadian Blood Services